# Helicobacter Pylori Eradication and Irritable Bowel Syndrome: A Prospective Study

> **NCT04512898** · PHASE4 · UNKNOWN · sponsor: **Assiut University** · enrollment: 100 (estimated)

## Conditions studied

- Irritable Bowel Syndrome

## Interventions

- **DRUG:** Triple therapy for H.pylori

## Key facts

- **NCT ID:** NCT04512898
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08-10
- **Primary completion:** 2020-11-10
- **Final completion:** 2020-11-10
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04512898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04512898, "Helicobacter Pylori Eradication and Irritable Bowel Syndrome: A Prospective Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04512898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*